QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 20, 2005, 25(29):6845-6856; doi:10.1523/JNEUROSCI.0442-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (52) Citing Articles via Google Scholar Google Scholar Articles by Bodor, A. L. Articles by Freund, T. F. Search for Related Content PubMed PubMed Citation Articles by Bodor, A. L. Articles by Freund, T. F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Endocannabinoid Signaling in Rat Somatosensory Cortex: Laminar Differences and Involvement of Specific Interneuron Types

Ágnes L. Bodor,¹ István Katona,¹ Gábor Nyíri,¹ Ken Mackie,² Catherine Ledent,³ Norbert Hájos,¹ and Tamás F. Freund¹

¹Department of Cellular and Network Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary, ²Departments of Anesthesiology, Physiology, and Biophysics, University of Washington, Seattle, Washington 98195, and ³Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, 1070 Brussels, Belgium

Endocannabinoid-mediated retrograde signaling exerts powerful control over synaptic transmission in many brain areas. However, in the neocortex, the precise laminar, cellular, and subcellular localization of the type 1 cannabinoid receptor (CB₁) as well as its function has been elusive. Here we combined multiple immunolabeling with whole-cell recordings to investigate the morpho-functional characteristics of cannabinoid signaling in rat somatosensory cortex.

Immunostaining for CB₁ revealed axonal and somatic labeling with striking layer specificity: a high density of CB₁-positive fibers was seen in layers II-III, in layer VI, and in upper layer V, whereas other layers had sparse (layer IV) or hardly any (layer I) staining. Membrane staining for CB₁ was only found in axon terminals, all of which contained GABA and formed symmetric synapses. Double immunostaining also revealed that CB₁-positive cells formed two neurochemically distinct subpopulations: two-thirds were cholecystokinin positive and one-third expressed calbindin, each subserving specific inhibitory functions in cortical networks.

In addition, cannabinoid sensitivity of GABAergic input showed striking layer specificity, as revealed by both electrophysiological and anatomical experiments. We found a unique population of large pyramidal neurons in layer VB that received much less perisomatic innervation from CB₁-expressing GABAergic axon terminals and, accordingly, showed no depolarization-induced suppression of inhibition, unlike pyramidal cells in layer II, and a population of small pyramidal cells in layer V. This suggests that inhibitory control of pyramidal cells involved in intracortical or corticostriatal processing is fine-tuned by activity-dependent endocannabinoid signaling, whereas inhibition of pyramidal cells relaying cortical information to lower subcortical effector centers often lacks this plasticity.

Key words: cholecystokinin; DSI; GABA; interneurons; parvalbumin; retrograde signaling

---

Received Feb 2, 2005; revised May 20, 2005; accepted June 6, 2005.

This article has been cited by other articles:

				S. M. Eggan, Y. Mizoguchi, S. R. Stoyak, and D. A. Lewis Development of Cannabinoid 1 Receptor Protein and Messenger RNA in Monkey Dorsolateral Prefrontal Cortex Cereb Cortex, August 24, 2009; (2009) bhp179v1. [Abstract] [Full Text] [PDF]

				P. D. Morrison and R. M. Murray From Real-World Events to Psychosis: The Emerging Neuropharmacology of Delusions Schizophr Bull, July 1, 2009; 35(4): 668 - 674. [Abstract] [Full Text] [PDF]

				Y. M. Morozov, M. Torii, and P. Rakic Origin, Early Commitment, Migratory Routes, and Destination of Cannabinoid Type 1 Receptor-Containing Interneurons Cereb Cortex, July 1, 2009; 19(suppl_1): i78 - i89. [Abstract] [Full Text] [PDF]

				Y. Zhao, M. E. Rubio, and T. Tzounopoulos Distinct Functional and Anatomical Architecture of the Endocannabinoid System in the Auditory Brainstem J Neurophysiol, May 1, 2009; 101(5): 2434 - 2446. [Abstract] [Full Text] [PDF]

				M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-Mediated Control of Synaptic Transmission Physiol Rev, January 1, 2009; 89(1): 309 - 380. [Abstract] [Full Text] [PDF]

				S. Marinelli, S. Pacioni, T. Bisogno, V. Di Marzo, D. A. Prince, J. R. Huguenard, and A. Bacci The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons J. Neurosci., December 10, 2008; 28(50): 13532 - 13541. [Abstract] [Full Text] [PDF]

				H.-C. Lin, S.-C. Mao, P.-S. Chen, and P.-W. Gean Chronic cannabinoid administration in vivo compromises extinction of fear memory Learn. Mem., December 2, 2008; 15(12): 876 - 884. [Abstract] [Full Text] [PDF]

				M. Galarreta, F. Erdelyi, G. Szabo, and S. Hestrin Cannabinoid Sensitivity and Synaptic Properties of 2 GABAergic Networks in the Neocortex Cereb Cortex, October 1, 2008; 18(10): 2296 - 2305. [Abstract] [Full Text] [PDF]

				S. M. Eggan, T. Hashimoto, and D. A. Lewis Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia Arch Gen Psychiatry, July 1, 2008; 65(7): 772 - 784. [Abstract] [Full Text] [PDF]

				P. J. Sjostrom, E. A. Rancz, A. Roth, and M. Hausser Dendritic Excitability and Synaptic Plasticity Physiol Rev, April 1, 2008; 88(2): 769 - 840. [Abstract] [Full Text] [PDF]

				F. Lemtiri-Chlieh and E. S. Levine Lack of Depolarization-Induced Suppression of Inhibition (DSI) in Layer 2/3 Interneurons That Receive Cannabinoid-Sensitive Inhibitory Inputs J Neurophysiol, November 1, 2007; 98(5): 2517 - 2524. [Abstract] [Full Text] [PDF]

				E. Carter and X.-J. Wang Cannabinoid-Mediated Disinhibition and Working Memory: Dynamical Interplay of Multiple Feedback Mechanisms in a Continuous Attractor Model of Prefrontal Cortex Cereb Cortex, September 1, 2007; 17(suppl_1): i16 - i26. [Abstract] [Full Text] [PDF]

				M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum J. Neurosci., April 4, 2007; 27(14): 3663 - 3676. [Abstract] [Full Text] [PDF]

				E. L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons J Neurophysiol, April 1, 2007; 97(4): 2580 - 2589. [Abstract] [Full Text] [PDF]

				K. Chen, A. Neu, A. L. Howard, C. Foldy, J. Echegoyen, L. Hilgenberg, M. Smith, K. Mackie, and I. Soltesz Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures J. Neurosci., January 3, 2007; 27(1): 46 - 58. [Abstract] [Full Text] [PDF]

				D. A. Fortin and E. S. Levine Differential Effects of Endocannabinoids on Glutamatergic and GABAergic Inputs to Layer 5 Pyramidal Neurons Cereb Cortex, January 1, 2007; 17(1): 163 - 174. [Abstract] [Full Text] [PDF]

				S. M. Eggan and D. A. Lewis Immunocytochemical Distribution of the Cannabinoid CB1 Receptor in the Primate Neocortex: A Regional and Laminar Analysis Cereb Cortex, January 1, 2007; 17(1): 175 - 191. [Abstract] [Full Text] [PDF]

				E. S. Graham, N. Ball, E. L. Scotter, P. Narayan, M. Dragunow, and M. Glass Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway J. Biol. Chem., September 29, 2006; 281(39): 29085 - 29095. [Abstract] [Full Text] [PDF]

				L. J. Sim-Selley, N. S. Schechter, W. K. Rorrer, G. D. Dalton, J. Hernandez, B. R. Martin, and D. E. Selley Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration Mol. Pharmacol., September 1, 2006; 70(3): 986 - 996. [Abstract] [Full Text] [PDF]

				S. R. Laviolette and A. A. Grace Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. J. Neurosci., June 14, 2006; 26(24): 6458 - 6468. [Abstract] [Full Text] [PDF]

				T. Yoshida, M. Fukaya, M. Uchigashima, E. Miura, H. Kamiya, M. Kano, and M. Watanabe Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci., May 3, 2006; 26(18): 4740 - 4751. [Abstract] [Full Text] [PDF]

				Y. Kawamura, M. Fukaya, T. Maejima, T. Yoshida, E. Miura, M. Watanabe, T. Ohno-Shosaku, and M. Kano The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci., March 15, 2006; 26(11): 2991 - 3001. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help